UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~August~~ 20October 10, 2013

Vansen Pharma Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-33715		20-2881151
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

101 Convention Centre Drive, Suite 700, Las Vegas, NV		89109
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (514) ~~775~~502-~~636-6986~~9494

~~Okana~~N/A ~~Ventures, Inc.~~ (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.03	Amendments to Articles of Incorporation or Bylaws
Item 8.01	Other Items

Item 4.01

Changes in Registrant’s Certifying Accountant.

~~On August 7, 2013, our board of directors approved an agreement and plan of merger to merge with our wholly-owned subsidiary Vansen Pharma Inc.,~~ (a) ~~Nevada~~Our ~~corporation,~~previous toindependent ~~effect~~registered apublic ~~name~~accounting ~~change from Okana Ventures, Inc. to Vansen Pharma Inc. Vansen Pharma Inc. was formed solely for the change of name.~~firm:

~~Articles~~(i) ofOn ~~Merger~~October to10, ~~effect~~2013, ~~the~~our ~~merger~~company ~~and~~formally ~~change~~informed ofMalone ~~name~~Bailey ~~were~~LLP, ~~filed~~Certified ~~and~~Public ~~became~~Accounting ~~effective~~Firm ~~with~~of ~~the~~their ~~Nevada~~dismissal ~~Secretary~~as ofour ~~State~~company’s onindependent ~~August~~registered ~~20,~~public ~~2013~~accounting firm.

~~In addition to the name change, our board of directors approved a 12 new for one~~ (1ii) ~~old~~Malone ~~forward~~Bailey ~~split~~LLP ofhad ~~our~~not ~~authorized and~~ issued ~~and~~any ~~outstanding~~audit ~~shares~~reports ofor ~~common~~other opinions. AThere ~~Certificate~~were ofno ~~Change~~disagreements ~~for~~with ~~the~~Malone ~~stock~~Bailey ~~split~~LLP ~~was~~on ~~filed~~any ~~and~~matters ~~became effective with the Nevada Secretary~~ of ~~State~~accounting onprinciples ~~August~~or 20practices, ~~2013.~~financial ~~Consequently,~~statement ~~our authorized share capital increased from 100~~disclosure,~~000,000~~ toor ~~1,200,000,000~~auditing ~~shares~~scope ~~of common stock~~ and ~~our~~procedures. ~~issued~~Our ~~and~~financial ~~outstanding~~statements ~~common~~for ~~stock~~the ~~increased~~years ~~from7,066,667~~ended toDecember 8431,~~800,004~~ ~~shares,~~2012 ~~all~~and ~~with~~2011 awere ~~par~~audited ~~value~~by ofother $0auditors.~~001.~~

~~These~~(iii) ~~amendments~~Our ~~have~~company’s ~~been~~Board ~~reviewed~~of byDirectors ~~the~~participated ~~Financial~~in ~~Industry Regulatory Authority (FINRA)~~ and ~~have been~~ approved ~~for~~the ~~filing~~decision ~~with~~to anchange ~~effective~~independent ~~date~~registered ofpublic ~~August~~accounting ~~30, 2013~~firms.

~~The~~(iv) ~~forward~~Through ~~split~~the ~~and~~interim ~~name~~periods ~~change~~(subsequent ~~will~~to ~~become~~our ~~effective~~year ~~with~~ended ~~the~~December ~~Over-the-Counter~~31, ~~Bulletin~~2012) ~~Board~~to atOctober 10, 2013 (the ~~opening~~date of ~~trading~~change onin ~~August 30~~accountants), ~~2013~~there ~~under~~have ~~the~~been ~~symbol~~no ~~“OKNVD”.~~disagreements ~~The~~with ~~"D"~~Malone ~~will~~Bailey beLLP ~~placed~~ on ~~our~~any ~~ticker~~matter ~~symbol~~of ~~for~~accounting 20principles ~~business~~or ~~days.~~practices, ~~Effective~~financial ~~September~~statement 30disclosure, ~~2013~~or auditing scope or procedure, ~~our~~which ~~ticker~~disagreements, ~~symbol~~if ~~will~~not ~~change~~resolved to ~~VNSN.~~the ~~Our~~satisfaction ~~new~~of ~~CUSIP~~Malone ~~number~~Bailey isLLP, ~~92209Y101~~would have caused them to make reference to the subject matter of the disagreements in connection with their report on the financial statements for such years.

Item 9.01		Financial Statements and Exhibits
3.1		Articles of Merger filed with the Nevada Secretary of State on August 14, 2013 with an effective date of August 20, 2013.
3.2		Certificate of Change filed with the Nevada Secretary of State on August 14, 2013 with an effective date of August 20, 2013.

(v)	Our company has requested that Malone Bailey LLP furnish us with a letter addressed to the SEC stating whether or not it agrees with the above statements. The letter of Malone Bailey LLP is incorporated into this report as Exhibit 16.1.

(b)	New independent registered public accounting firm:

On October 10, 2013, our company engaged Saturna Group Chartered Accountants LLP as our new independent registered public accounting firm. During the two most recent fiscal years and through October 10, 2013, our company had not consulted with Saturna Group Chartered Accountants LLP regarding any of the following:

(i)	The application of accounting principles to a specific transaction, either completed or proposed;

(ii)

The type of audit opinion that might be rendered on our company’s financial statements, and none of the following was provided to our company: (a) a written report, or (b) oral advice was provided that Saturna Group Chartered Accountants LLP concluded was an important factor considered by our company in reaching a decision as to accounting, auditing or financial reporting issue; or

(iii)

Any matter that was subject of a disagreement, as that term is defined in Item 304(a)(1)(iv) of Regulation S-K.

Item 9.01

Financial Statements and Exhibits

16.1	Letter from Malone Bailey LLP to the Securities and Exchange Commission.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

VANSEN PHARMA INC. /s/ Richard Azani Richard Azani President and Director Date: August 30, 2013

	VANSEN PHARMA INC.

Date: October 28, 2013	By:	/s/ Richard Azani
		Richard Azani
		President and Director

Filing Compare · Vansen Pharma Inc.